One woman has been reportedly killed and about 15 injured in six blasts that rocked the southern city of Bangalore today (July 25), police officials said. Confirming the reports of blasts, Police Commissionser of Bangalore — Shankar Bidri — said that expolsives were hidden in relatively crowded areas of the city. The first blast took place at around 1:30 pm at the Madivala checkpost in the city. The other blasts have been reported from Adugudi, Ashoknagar, Hosur, Koramangala and Langford town.
Pharma reps have been getting a tough shake lately, what with massive layoffs and a new industry code that curtails some tried-and-true sales techniques. Not to mention efforts to ban them altogether from various academic institutions and even require licensing in the District of Columbia. Now, though, a new study offers a welcome respite: More than three-fourths of doctors say they’re willing to see reps any time of day, and only one-fourth require an appointment.
17 percent of the 230,000 medical practices surveyed said they don’t admit reps at all. Some 30 percent of hospital-owned practices bar reps, and another 40 percent require appointments. But still, that leaves 83 percent of docs open to sales-rep input.
See the doc survey at Pharmalot
The US Food and Drug Administration (FDA) is pushing for Congress to approve the use of more third-party inspectors as the regulatory body attempts to police a complex global supply chain.
The Government Accountability Office (GAO) has stated that foreign plants are inspected every 13 years as opposed to 2.7 years for facilities in the US, a situation the FDA is hoping to resolve.
However, the outsourcing plan has already drawn criticism, primarily targeted at the perceived failure of a similar scheme for inspections of device manufacturers.
The outsourcing idea was mooted last autumn, when the Bush administration proposed a plan for non-FDA inspections of prescription pharmaceuticals. This would be done on a voluntary basis for products that are not considered to pose too great a risk, with manufacturers paying for the inspections.